FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37061411000001103: Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44341000001117 Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
44351000001119 Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Bendamustine 25mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient Bendamustine hydrochloride true Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) 5 vial Has AMP True Bendamustine 25mg powder for concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start